GRI
GRI Bio Inc.
NASDAQ: GRI · HEALTHCARE · BIOTECHNOLOGY
$2.18
-2.25% today
Updated 2026-04-30
Market cap
$3.41M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-121.80
Dividend yield
—
52W range
$2 – $80
Volume
0.1M
GRI Bio Inc. (GRI) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $639231.00 | $4.28M | $955000.00 | $218000.00 | $383000.00 | $2.96M | $5.74M | $8.67M |
| Cash & equivalents | $612652.00 | $3.82M | $109000.00 | $90000.00 | $9000.00 | $1.81M | $5.03M | $8.23M |
| Current assets | $637639.00 | $3.92M | $674000.00 | $96000.00 | $312000.00 | $2.93M | $5.62M | $8.59M |
| Total liabilities | $486292.00 | $1.06M | $2.41M | $4.94M | $2.01M | $2.70M | $1.71M | $2.66M |
| Current liabilities | $486292.00 | $807498.00 | $2.23M | $4.88M | $1.99M | $2.70M | $1.64M | $2.64M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Shareholder equity | $152939.00 | $3.21M | $-1.45M | $-4.72M | $-1.63M | $259000.00 | $4.03M | $6.01M |
| Retained earnings | $-4.31M | $-7.78M | $-12.60M | $-15.28M | $-18.50M | $-31.53M | $-39.74M | $-51.70M |
| Accounts receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — |